XTL BIOPHARMACEUTICALS LTD. Other Comprehensive Income Before Tax
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Other Comprehensive Income Before Tax of -$1.03 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeBeforeTax · last filed 2025-04-30
| Period end | Other Comprehensive Income Before Tax 12 month |
|---|---|
| 2024-12-31 | -$1.03M 20-F · filed 2025-04-30 |
| 2023-12-31 | -$1.78M 20-F · filed 2025-04-30 |
| 2022-12-31 | -$1.35M 20-F · filed 2025-04-30 |
| 2021-12-31 | $435.00K 20-F · filed 2023-03-22 |
| 2020-12-31 | -$2.95M 20-F · filed 2023-03-22 |
| 2019-12-31 | -$763.00K 20-F · filed 2022-03-30 |